697-56336-14406 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-05
Registered in v-safe
2021-03-05
Survey response — days 1–6 daily, dose 1
MedDRA: Flushing, Hypoaesthesia, Paraesthesia, Photophobia, Swelling face, Vision blurred — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: The day of the shot, 30 mins after, my face swole up and became tingly then numb, I became very flushed and my vision became blurry and I became sensitive to light. Im still having trouble with my vision today.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-06
Survey response — days 1–6 daily, dose 1
MedDRA: Photophobia, Vision blurred — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Vision blurry and eyes sensitive to light

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-08
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain, Photophobia, Vision blurred — Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Eye pain, blur rinsed and light sensitivity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-09
Survey response — days 1–6 daily, dose 1
MedDRA: Photophobia, Vision blurred — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Blurred vision and light sensitivity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain, Photophobia, Vision blurred — Feeling: Fair · Fever · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Vision blurred. Eye pain. Sensitivity to light.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-11
Survey response — day 7, dose 1
MedDRA: Photophobia, Vision blurred — Feeling: Fair · Fatigue or tiredness

Free text: Blurred vision and light sensitivity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-18
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-03-25
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-02
Health check-in — day 28, dose 1
Feeling: Fair

Adult check-in
2021-04-17
Survey response — day 42, dose 1
MedDRA: Visual impairment — Feeling: Good

Free text: Still having problems with my vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-03
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-09-02
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-03-06
Survey response — 12 months, dose 1
MedDRA: Arthralgia, Cough, Headache, Inflammation, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cough, inflammation, joint pain, fever, headache.

MedDRA releases: 2024-11 · check-in free text available
2022-03-06
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-09
Call 1 — Could Not Reach Participant
2022-03-14
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-05

Systemic reaction (other): The day of the shot, 30 mins after, my face swole up and became tingly then numb, I became very flushed and my vision became blurry and I became sensitive to light. Im still having trouble with my vision today.

2021-03-06

Systemic reaction (other): Vision blurry and eyes sensitive to light

2021-03-08

Systemic reaction (other): Eye pain, blur rinsed and light sensitivity

2021-03-09

Systemic reaction (other): Blurred vision and light sensitivity

2021-03-10

Systemic reaction (other): Vision blurred. Eye pain. Sensitivity to light.

Release 5 — day 7, dose 1

2021-03-11

Systemic reaction (other): Blurred vision and light sensitivity

Release 7 — day 42, dose 1

2021-04-17

Symptoms: Still having problems with my vision

Release 11 — 12 months, dose 1

2022-03-06

Symptoms: Cough, inflammation, joint pain, fever, headache.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	·	·	✓
SD	Cough	·	·	✓
SD	Headache	·	·	✓
SD	Inflammation	·	·	✓
SD	Pyrexia	·	·	✓
SD	Visual impairment	✓	✓	✓
SRO	Eye pain	✓	✓	✓
SRO	Flushing	✓	✓	✓
SRO	Hypoaesthesia	✓	✓	✓
SRO	Paraesthesia	✓	✓	✓
SRO	Photophobia	✓	✓	✓
SRO	Swelling face	✓	✓	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release